Unknown

Dataset Information

0

Clinicopathological significance and underlying molecular mechanism of downregulation of basonuclin 1 expression in ovarian carcinoma.


ABSTRACT: In this study, we aim to identify the clinical significance of basonuclin 1 (BNC1) expression in ovarian carcinoma (OV) and to explore its latent mechanisms. Via integrating in-house tissue microarrays, gene chips, and RNA-sequencing data, we explored the expression and clinical value of BNC1 in OV. Immunohistochemical staining was utilized to confirm the protein expression status of BNC1. A combined SMD of -2.339 (95% CI: -3.649 to -1.028, P <0.001) identified that BNC1 was downregulated based on 1346 samples, and the sROC (AUC = 0.93) showed a favorable discriminatory ability of BNC1 in OV patients. We used univariate and multivariate Cox regulation to evaluate the prognostic role of BNC1 for OV patients, and a combined hazard ratio of 0.717 (95% CI: 0.445-0.989, P <0.001) revealed that BNC1 was a protective factor for OV. Furthermore, the fraction of infiltrating naive B cells, memory B cells, and other immune cells showed statistical differences between the high- and low-BNC1 expression groups through cell-type identification by estimating relative subsets of RNA transcripts (CIBERSORT) algorithm. Enrichment analysis showed that BNC1 may have a relationship with immune-related items in OV. By predicting the potential regulatory transcription factors (TFs) of BNC1, friend leukemia virus integration 1 (FLI1) may be a potential upstream TF of BNC1. Corporately, a decreasing trend of BNC1 may serve as a tumor suppressor and prognostic biomarker in OV patients. Moreover, BNC1 may take part in immune-related pathways and influence the fraction of tumor-infiltrating immune cells.

SUBMITTER: Liang ZQ 

PROVIDER: S-EPMC8777474 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Clinicopathological significance and underlying molecular mechanism of downregulation of basonuclin 1 expression in ovarian carcinoma.

Liang Zi-Qian ZQ   Zhong Lu-Yang LY   Li Jie J   Shen Jin-Hai JH   Tu Xin-Yue XY   Zhong Zheng-Hong ZH   Zeng Jing-Jing JJ   Chen Jun-Hong JH   Wei Zhu-Xin ZX   Dang Yi-Wu YW   Huang Su-Ning SN   Chen Gang G  

Experimental biology and medicine (Maywood, N.J.) 20211013 2


In this study, we aim to identify the clinical significance of basonuclin 1 (<i>BNC1</i>) expression in ovarian carcinoma (OV) and to explore its latent mechanisms. Via integrating in-house tissue microarrays, gene chips, and RNA-sequencing data, we explored the expression and clinical value of <i>BNC1</i> in OV. Immunohistochemical staining was utilized to confirm the protein expression status of BNC1. A combined SMD of -2.339 (95% <i>CI</i>: -3.649 to -1.028, <i>P </i><<i> </i>0.001) identifie  ...[more]

Similar Datasets

| S-EPMC5647073 | biostudies-literature
| S-EPMC7005787 | biostudies-literature
| S-EPMC3100854 | biostudies-literature
| S-EPMC3916713 | biostudies-literature
| S-EPMC11292461 | biostudies-literature
| S-EPMC3449188 | biostudies-literature
| S-EPMC7464028 | biostudies-literature
| S-EPMC5908574 | biostudies-literature
| S-EPMC7219755 | biostudies-literature
| S-EPMC7591459 | biostudies-literature